- Home
- LFCR
as 12-20-2024 3:38pm EST
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
| Founded: | 1986 | Country: | United States |
| Employees: | N/A | City: | CHASKA |
| Market Cap: | 164.3M | IPO Year: | N/A |
| Target Price: | $10.00 | AVG Volume (30 days): | 209.5K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.17 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.68 - $8.90 | Next Earning Date: | 01-02-2025 |
| Revenue: | $128,443,999 | Revenue Growth: | 23.42% |
| Revenue Growth (this year): | 2.23% | Revenue Growth (next year): | 8.40% |
Stock Insider Trading Activity of Lifecore Biomedical Inc. (LFCR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | LFCR | 10% Owner | Oct 3 '24 | Buy | $4.10 | 292,683 | $1,200,000.30 | 2,095,783 | |
| Kiper Christopher S | LFCR | Director10% Owner | Oct 3 '24 | Buy | $4.10 | 1,463,414 | $5,999,997.40 | 4,084,268 |
Latest Lifecore Biomedical Inc. News
LFCR Breaking Stock News: Dive into LFCR Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
GlobeNewswire
3 days ago
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
Insider Monkey
10 days ago
Here’s Why Arquitos Capital Management Largely Exited Lifecore (LFCR)
Simply Wall St.
19 days ago
Lifecore Biomedical (NASDAQ:LFCR) investors are sitting on a loss of 33% if they invested five years ago
MT Newswires
a month ago
Lifecore Biomedical Amends, Extends Credit Facility
GlobeNewswire
a month ago
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO
GlobeNewswire
a month ago
Lifecore Biomedical Hosts Virtual Investor Day
Insider Monkey
a month ago
Here’s Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR)
Compare LFCR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LFCR Lifecore Biomedical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.